Source: Medthority

Bristol-Myers Squibb: FDA Approves Opdivo + Yervoy

FDA approves Opdivo and Yervoy combo for first-line treatment of unresectable or metastatic hepatocellular carcinoma.

Read full article »
Bristol-Myers Squibb's Competitors | Bristol-Myers Squibb's News | Bristol-Myers Squibb's Financials
Stay up-to-date with the latest news on Bristol-Myers Squibb
Annual Revenue
$10-50B
Employees
10-50K
Christopher Boerner's photo - CEO of Bristol-Myers Squibb

CEO

Christopher Boerner

CEO Approval Rating

46/100

Read more
Stay up-to-date with the latest news on Bristol-Myers Squibb